HDBuzz – Page 27 – Huntington’s disease research news.

Huntington’s disease research news.

In plain language. Written by scientists.
For the global HD community.

Putting Huntington’s disease medications to the test: results from the Neuro-HD trial

January 8, 2026

Latest News

HDBuzz Is Officially Independent: What This Means, and Why It Matters

We’re entering a new chapter. HDBuzz is now an independent organisation, strengthening our ability to report clearly, critically, and responsibly on HD research.

January 5, 2026

Huntington's Disease Therapeutics Conference 2017 – Day 3

HDBuzz summarises final day of the 2017 Huntington's Disease Therapeutics Conference in Malta

April 30, 2017
Huntington's Disease Therapeutics Conference 2017 – Day 2

HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta – day 2

April 29, 2017
Huntington's Disease Therapeutics Conference 2017 – Day 1

HDBuzz summarises all the science from the 2017 Huntington's Disease Therapeutics Conference in Malta – day 1

April 27, 2017
Enemy at the gates – huntingtin disrupts nuclear transport

Two recent studies show how a cellular border control system goes wrong in HD, opening new avenues for HD research.

April 21, 2017
FDA approves a new drug for symptoms of Huntington's disease

Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease

April 5, 2017
Sheep leading the flock: metabolism and biomarkers in HD

Sheep can help us to identify HD biomarkers and recognize metabolic changes that occur before symptoms develop.

March 27, 2017
Weeding out the truth: can cannabis improve Huntington’s?

What can individual experiences with cannabis tell us about Huntington's disease?

February 24, 2017
Huntingtin grabs a hammer: DNA repair in HD

Huntingtin helps fix damaged DNA, a recent study suggests, under the direction of a gene repair protein called ATM.

February 22, 2017
The benefits of migration, highlighted in Huntington's disease

Is HD a developmental disease? HD stops neurons migrating in developing brain, but maybe we can get them going again

February 10, 2017
Treasure your exceptions – using outliers to understand Huntington's disease onset and progression

A new study provides the framework for finding factors that affect the onset and progression of HD

January 12, 2017

HDBuzz Trial Tracker

Request Meeting with FDA to Define Next Steps for AMT-130

uniQure

Expected: Q1 2026

Topline data from SKY-0515’s Phase 1 Clinical Study

Skyhawk Therapeutics

Expected: Mid 2026

Phase 3 for SOM3355 to commence

SOM Biotech

Expected: Q4 2026

Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02

Alnylam Pharmaceuticals

Expected: 2026

GENERATION-HD2 Trial Expected to Complete

Roche

Expected: 2026

Update on Planned Phase 2/3 Study for WVE-003

Wave Life Sciences

Expected: Not disclosed

Update on Phase 1/2a Clinical Data of VO659

Vico Therapeutics

Expected: Not disclosed

Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam

Novartis/PTC Therapeutics

Expected: Not disclosed

Previously featured

HDBuzz Is Officially Independent: What This Means, and Why It Matters

January 5, 2026
2025: Year in Review

December 29, 2025
Break Up With Your CAGs: How Three Letters Could Change Huntington’s Disease

December 22, 2025
First participants dosed in new POINT-HD huntingtin-lowering trial

December 18, 2025
A road less traveled: how making less huntingtin can alter somatic instability and may delay symptoms

December 15, 2025

Start here

New to HD Research? Click here to get an overview

Follow HDBuzz

Sign up to our monthly email summary by entering your email address on our mailing list page.

Suggest an article

Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.

Email editors@hdbuzz.net